8:00am – 5:00pm

GeT-RM Panel Meeting 2010

11:30am – 6:00pm

AMP Council Meeting

12:00pm – 6:00pm

Registration, Check-in

  6:30pm

Council Dinner

7:00am – 5:00pm

Registration, Check-in

7:30am – 3:30pm

Pathology Outreach Program: Real Time Updates and New Clinical Applications in Molecular Pathology
separate registration required)

Presented by the AMP Training & Education Committee

Supported by an Unrestricted educational grant from Nanosphere, Inc.

9:00am – 6:00pm

Corporate Workshops - (See Separate Schedule)

7:00am – 7:00pm

AMP Committee & Working Group Meetings

      7:30am –  9:30am

Economic Affairs Committee                                                              

      9:00am – 10:00am

Clinical Practice Committee

     10:00am – 11:00am

Publications Committee (10:30– 11:00am with Web Ed Board)

     10:30am – 11:30am

Web Editorial Board (10:30am – 11:00am with Pubs)

     11:30am – 12:00pm

Nominating Committee

     12:00pm – 2:00pm

Strategic Planning Committee

       2:00pm – 3:00pm

Membership & Professional Development Committee

       3:00pm – 4:00pm

2010 Program Committee

       4:00pm – 5:00pm

2011 Program Committee

       4:00pm – 5:00pm

Training & Education Committee

       4:00pm – 6:00pm

Professional Relations Committee

       6:00pm – 7:00pm

International Affairs Working Group

5:00pm – 7:00pm

Dialogue with NIST: Standard Reference Materials for Molecular Diagnostics

John M. Butler, PhD, National Institute of Standards and Technology, Gaithersburg, MD

6:00pm – 7:00pm

MGP Program Directors Meeting

7:00am – 5:00pm

Registration, Check-in

7:00am – 8:00am

Continental Breakfast

7:00am – 8:00am

EARLY BIRD SESSIONS

Update on Standardization of BCR-ABL Testing

Suzanne Kamel-Reid, PhD, FACMG, The University Health Network, Toronto, ON Canada

Challenging Cases

Marina N. Nikiforova, MD, University of Pittsburgh Medical School, Pittsburgh, PA

Loren Joseph, MD, University of Chicago School of Medicine, Chicago, IL

8:00am – 8:15am

Break

8:15am – 8:30am

Opening Remarks

Barbara Zehnbauer, PhD, Centers for Disease Control and Prevention, Atlanta, GA

8:30am – 10:00am

AMP AWARD FOR EXCELLENCE IN MOLECULAR DIAGNOSTICS
Supported by an unrestricted educational grant from Roche Diagnostics Corporation

The Dark Matter of Biological Regulation

Patrick O. Brown, MD, PhD, Stanford University, Stanford, CA

10:00am – 10:30am

Break

10:30am – 12:00pm

PLENARY SESSION I: SOLID TUMORS

Molecular Diagnosis and Prognosis for Breast Cancer

Moderators: Loren Joseph, MD, University of Chicago School of Medicine, Chicago, IL, and
George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD

Single Cell Analysis of Circulating Tumor Cells in Cancer

Stefanie S. Jeffrey, MD, Stanford University School of Medicine, Stanford, CA

Genomic Approaches to Predictive and Prognostic Markers in Breast Cancer
Joe W. Gray, PhD, Lawrence Berkeley National Laboratory, Berkeley, CA

12:00pm – 1:00pm

General Lunch

Infectious Diseases Business Lunch

Solid Tumors Business Lunch

1:00pm – 2:30pm

CONCURRENT WORKSHOPS

Platform Presentation of Selected Abstracts - Genetics

Moderators: Arlene M. Buller-Burckle, PhD, HCLD, Quest Diagnostics Nichols Institute and D. Brian Dawson, PhD, Mayo Clinic, Rochester, MN

Platform Presentation of Selected Abstracts - Hematopathology

Moderators: Timothy C. Greiner, MD, University of Nebraska Medical Center, Omaha, NE and Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA

Technical Topics – Regulatory Perspective from CAP and FDA

Moderator: Gail H. Vance, MD, FCAP, Indiana University School of Medicine, Indianapolis, IN

The CAP Perspective

Gail H. Vance, MD, FCAP, Indiana University School of Medicine, Indianapolis, IN

The FDA Perspective

Alberto Gutierrez, PhD, OIVD/CDRH/FDA, Silver Spring, MD

2:30pm – 4:00pm

Break, Visit Posters & Exhibits: Even-numbered and Award posters manned

4:00pm – 5:30pm

PLENARY SESSION II:  INFECTIOUS DISEASES

Uncultured Pathogens

Moderator: David H. Persing, MD, PhD, Cepheid Inc., Sunnyvale, CA

Bacterial Vaginosis

Dave N. Fredericks, MD, Fred Hutchison Cancer Research Center, Seattle, WA

Whipple’s Disease

Florence Fenollar, MD, PhD, Universite de la Mediterranee, Marseille, France

6:00pm – 7:00pm

Welcome Reception

Supported by  Roche Diagnostics

(The AMP International Affairs Working Group invites non-U.S. meeting attendees to meet with them near the end of the Welcome Reception.)

7:00pm – 9:00pm

JMD Editorial Board Meeting

7:00pm – 11:00pm

Canadian Members’ Dinner

7:00am – 6:00pm

Registration, Check-in

7:00am – 8:00am

Continental Breakfast

7:00am – 8:00am

EARLY BIRD SESSIONS

Panel Testing Using Next Generation Sequencing
Madhuri R Hegde PhD, Emory University School of Medicine, Atlanta, GA

How To Write a Scientific Manuscript
Karen Kaul, MD, PhD, Northshore University Health System, Evanston, IL
Gregory J. Tsongalis, PhD, Dartmouth Medical School, Lebanon, NH
Alexandra Valsamakis, MD, PhD, The Johns Hopkins Medical Institutions, Baltimore, MD

Coding Conundrums in Molecular Pathology

Jeffrey A. Kant, MD PhD University of Pittsburgh Medical Center, Pittsburgh, PA

8:00am – 8:15am

Break

8:15am – 9:45am

PLENARY SESSSION III: GENETICS Cardiovascular Genetics
Moderator: Arlene M. Buller-Burckle, PhD, HCLD, Quest Diagnostics Nichols Institute

Dissecting the Genetic Causes of Cardiomyopathy

Jonathan Seidman, PhD, Harvard Medical School, Boston, MA

Genetic Testing for Inherited Cardiovascular Diseases
Elizabeth McNally, MD, PhD, University of Chicago, Chicago, IL

9:45am – 10:45am

Break, Visit Posters & Exhibits

10:45am – 12:15pm

CONCURRENT WORKSHOPS

Platform Presentation of Selected Abstracts – Infectious Diseases

Moderators: David H. Persing, MD, PhD, Cepheid Inc., Sunnyvale, CA, and
Randall T. Hayden, MD, St. Jude Children’s Research Hospital, Memphis, TN

Platform Presentation of Selected Abstracts – Solid Tumors

Moderators: Loren Joseph, MD, University of Chicago School of Medicine, Chicago, IL, and
George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD

Genetics – Technical, Clinical and Regulatory Aspects of Pharmacogenetics Testing – Panel Discussion

Moderator: Arlene M. Buller-Burckle, PhD, HCLD, Quest Diagnostics Nichols Institute

Pharmacogenetic Lessons from Plavix: Perspectives of a Genetic Benefit Manager

David G. Brooks, MD, PhD, Generation Health, Inc, Waltham, MA

Is Pharmacogenetics Missing the Target?

B. Dennis O’Kane, PhD, Mayo Clinic, Rochester, MN

Tamoxifen and Endofixen: Using Pharmacogenetics as a Tool for Drug Discovery

A. Matthew Goetz, MD, Mayo Clinic, Rochester, MN

12:15pm – 1:15pm

General Lunch

Genetics Business Lunch
Hematopathology Business Lunch

1:15pm – 2:15pm

Break, Visit Posters & Exhibits: Odd-numbered posters manned

2:15pm – 3:15pm

Special Topic Presentation

Clinical Applications of Next Generation Sequencing

Stephen Quake, PhD, Stanford University, Palo Alto, CA

2:15pm – 3:45pm

CONCURRENT WORKSHOPS

Technical Topics – Technical Troubles

Moderator: Angela M. Caliendo, MD, PhD, Emory University School of Medicine, Atlanta, GA

Genetics – Puzzlers by Prior

Moderator: Thomas W. Prior, PhD, Ohio State University, Columbus, OH

3:45pm – 4:00pm

Break

4:00pm – 5:30pm

CONCURRENT WORKSHOPS

Hematopathology - IGH BIOMED2 Interpretation Issues in B cell Neoplasias

Moderator: Charles E. Hill, MD, PhD, Emory University Hospital, Atlanta, GA

Evaluation of Immunoglobulin Gene Rearrangements using BIOMED-2/EuroClonality Diagnostic Clonality Testing

Patricia Groenen, PhD, Radboud University Nijmegen Medical Center, The Netherlands

Case Presentations

Daniel A. Arber, MD, Stanford University Medical Center, Stanford, CA

NIH Genetic Registry: Update and Dialogue

The NIH Genetic Test Registry Project
Cathy Fomous PhD, NIH Office of Biotechnology Activities, Bethesda, MD

AMP Response to NIH GTR RFI - Survey of Clinical Molecular Laboratories

Victoria Pratt, PhD, Quest Diagnostics, Nichols Institute, Chantilly, VA

5:30pm – 6:30pm

Business/Awards Session

6:30pm – 7:30pm

Awards Reception

Awards Reception and Technologist Award are supported by an unrestricted educational grant from Hologic

7:30pm – 10:30pm

Friday Evening Social Event

7:00am – 5:00pm

Registration, Check-in

7:00am – 8:00am

Continental Breakfast

7:00am – 8:00am

EARLY BIRD SESSIONS

Quality Assurance in the Clinical Molecular Laboratory

Jennifer L. Hunt, MD, Massachusetts General Hospital, Boston, MA

Margaret Gulley, MD, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC

Current Status of TB Testing

Beverly Metchock, DrPh,D (ABMM), Centers for Disease Control, Atlanta, GA

8:00am – 8:15am

Break

8:15am – 9:45am

PLENARY SESSION IV: Hematopathology

Advances from Whole Genome Studies in Acute Leukemias
Moderator: Timothy C. Greiner, MD, University of Nebraska Medical Center, Omaha, NE

Copy Number Variations and Mutations in Acute Lymphocytic Leukemia
Charles Mullighan, MBBS(Hons), MSc, MD, St. Jude Children’s Research Hospital, Memphis, TN

Sequencing the Genome of a Patient with Acute Myeloid Leukemia

Elaine R. Mardis, PhD, Washington University School of Medicine, St. Louis, MO

  9:45am – 10:30am

Break, Visit Posters & Exhibits

10:30am – 12:00pm

CONCURRENT WORKSHOPS

Solid Tumors –Cutting-edge Tools and Targets

Moderators: Loren Joseph, MD, University of Chicago School of Medicine, Chicago, IL, and
George J. Netto, MD, John Hopkins Medical Institutions, Baltimore, MD 

Complex Genetics of Breast Cancer Heterogeneity

Thomas Stricker, MD, PhD,  University of Chicago, Chicago, IL

Testing for IDH1 and IDH2 Mutations

Marina Nikiforova, MD, University of Pittsburgh, Pittsburgh, PA

Hematopathology - JAK2 and MPL Mutations

Moderator: Timothy C. Greiner, MD, University of Nebraska Medical Center, Omaha, NE

JAK2 and MPL Sample Exchange
Daniel Sabath, MD, PhD, University of Washington, Seattle, WA

Development of a Quantitative JAK Standard
Erasmus Schneider, PhD, Wadsworth Center, NY State Department of Health, Albany, NY

12:00pm – 1:00pm

General Lunch

Trainee Lunch

1:00pm – 2:30pm

CONCURRENT WORKSHOPS

Technical Topics - Next Generation Sequencing

Moderator: Karl V. Voelkerding, MD, ARUP Laboratories, Salt Lake City, UT

Translating Next Generation Sequencing into Clinical Diagnostics

Karl V. Voelkerding, MD, ARUP Laboratories, Salt Lake City, UT

Real Time DNA Sequencing From Single Polymerase Molecules

Steve W. Turner, PhD, Pacific Biosciences, Inc, Menlo Park, CA

Infectious Diseases - Quantitative Molecular Detection

Moderator: Randall T. Hayden, MD, St. Jude Children’s Research Hospital, Memphis, TN

Angela M. Caliendo, MD, PhD, Emory University School of Medicine, Atlanta, GA

Randall Hayden, MD, St. Jude Children’s Research Hospital, Memphis, TN

2:30pm – 3:00pm

Break

3:00pm – 4:30pm

PLENARY SESSION V: SPECIAL TOPICS

Infection and Cancer

Moderator: David H. Persing, MD, PhD, Cepheid Inc., Sunnyvale, CA and

Loren Joseph, MD, University of Chicago School of Medicine, Chicago, IL

HPV in Head and Neck Cancer – Validation of a Strong Prognostic Factor

Maura Gillison, MD, PhD, Ohio State University, Columbus, OH

Virus Discovery and Associations in Prostate Cancer, Head & Neck Cancers

Joseph DeRisi, PhD, University of California at San Francisco, San Francisco, CA

4:30pm – 4:45pm

Closing Remarks